Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines

Lukasz Zandecki; Agnieszka Janion-Sadowska; Jacek Kurzawski; Marianna Janion

doi:10.5114/ms.2020.96796

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2020
vol. 36

Send email

Copy url:

abstract:

Review paper

Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines

Lukasz Zandecki

^{1, 2}

,

Agnieszka Janion-Sadowska

³

,

Jacek Kurzawski

²

,

Marianna Janion

^{1, 2}

Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2nd Cardiology Clinic, Swietokrzyskie Cardiology Center, Kielce, Poland
Intensive Cardiac Care Unit, Swietokrzyskie Cardiology Center, Kielce, Poland

Medical Studies/Studia Medyczne 2020; 36 (2): 148–155

DOI: https://doi.org/10.5114/ms.2020.96796

Online publish date: 2020/06/30

View full text Get citation

PlumX metrics:

The prevalence of diabetes mellitus (DM) is steadily increasing all over the world. DM is associated with a doubling of cardiovascular (CV) risk independently of other risk factors. The European Society of Cardiology (ESC) in collaboration with the European Association for the Study of Diabetes (EASD) presented a new set of guidelines on diabetes, pre-diabetes and cardiovascular diseases at the ESC 2019 Congress in Paris. The most important changes in the guidelines include a new assessment of CV risk in DM patients, an algorithm for glucose-lowering treatment, prevention of CV diseases including new targets for the treatment of dyslipidemia taking into account CV risk and recommendations for antiplatelet/antithrombotic drugs. Furthermore, attention focused on the management of DM concomitant with coronary artery disease and heart failure, as well as individualized therapeutic strategies for diabetic patients with arterial hypertension.

keywords:

Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines

Lukasz Zandecki 1, 2 , Agnieszka Janion-Sadowska 3 , Jacek Kurzawski 2 , Marianna Janion 1, 2

diabetes, cardiovascular diseases, cardiovascular risk, ESC guidelines, pre-diabetes

Lukasz Zandecki

^{1, 2}

,

Agnieszka Janion-Sadowska

³

,

Jacek Kurzawski

²

,

Marianna Janion

^{1, 2}